Skip to content

Clinical trials

Observational Leukemia, Biphenotypic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Phase: Observational Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20072
20081
20093
20101
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNC Lineberger Comprehensive Cancer Center2
Case Comprehensive Cancer Center1
Children's Oncology Group1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
Memorial Sloan Kettering Cancer Center1
SWOG Cancer Research Network1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
St. Jude Children's Research Hospital1
Vanderbilt University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute11
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Hairy Cell9
Leukemia, Large Granular Lymphocytic9
Leukemia, Lymphocytic, Chronic, B-Cell9
Leukemia, Mast-Cell9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative9
Leukemia, Prolymphocytic9
Blast Crisis8
Leukemia, Myeloid, Accelerated Phase8

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.